Comparison of Aflibercept (Eylea®) with Ranibizumab (Lucentis®) in treatment of diabetic macular edema by Optical Coherence Tomography

Background: Diabetic macular edema (DME) can occur at any stage of non-proliferative and proliferative diabetic retinopathy. It is characterized by a swelling of the macular area that normally accounts for high-resolution visual acuity (VA), and DME therefore leads to visual deterioration. Objective...

Full description

Bibliographic Details
Main Authors: Hossam El din Khalil, Abdel Rahman Ahmed, Hassan Mahfouz Eliwa
Format: Article
Language:English
Published: Beni-Suef University, Faculty of Medicine 2022-04-01
Series:Egyptian Journal of Medical Research
Subjects:
Online Access:https://ejmr.journals.ekb.eg/article_240903_0a2753be9a04b656e6d6b935081ac6fa.pdf